Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

24.23 -0.16 (-0.66%)
Official Closing Price Updated: 4:10 PM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
ASSET PLANNING Exits Full Stake in Pfizer Worth $2.7 Million
Via The Motley Fool
Topics Regulatory Compliance
AI: The Medical Maverick – Navigating Hype and Hope in Healthcare’s Digital Revolution
Artificial intelligence (AI) stands at the precipice of a profound transformation in healthcare, promising a future where diagnostics are sharper, treatments are more personalized, and patient care is... 
Via TokenRing AI
Topics Artificial Intelligence
QSM Asset Management Takes $11.5 Million Stake in Rio Tinto, Expands Energy Exposure
Via The Motley Fool
Pfizer CEO Urges US-China Collaboration In Pharma; Stock Drops For 7th Day As Traders Hold For Dividend Payout
Via Stocktwits
Navigating the Currents: Volatility and Growth Define U.S. Markets Amidst AI Boom and Geopolitical Headwinds
As of October 16, 2025, the U.S. stock market is a tapestry woven with threads of robust corporate earnings, groundbreaking technological advancements, and persistent geopolitical and economic... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
QSM Asset Management Buys $6.8 Million of Pfizer Stock as Pharma Giant Lags Market
Via The Motley Fool
A Once-in-a-Decade Investment Opportunity: 1 Pharmaceutical Stock to Buy Now Hand Over Fist and Hold for Years
It's the best time in a while to scoop up shares of this stock from the discount bin. 
Via The Motley Fool
Topics Intellectual Property World Trade
Why Moderna Might Be a One-Hit Wonder
Moderna's sales have plummeted in recent years along with diminishing demand for COVID vaccines. 
Via The Motley Fool
Dividend Duo Delights Investors: Meta Platforms and Johnson & Johnson Shine in 2025
In a year marked by evolving market dynamics and a persistent search for both growth and stability, two distinct titans of industry—Meta Platforms (NASDAQ: META) and Johnson & Johnson (NYSE: JNJ)—have... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Curious about the most active S&P500 stocks in today's session?
Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Wednesday and uncover the stocks that are leading the way in terms of trading volume and market... 
Via Chartmill
Wall Street's Earnings Momentum Fades, Market Dips Amidst Trade Tensions
Wall Street witnessed a significant shift this Wednesday as an eagerly anticipated earnings push ultimately petered out, sending stocks into the red. This downturn followed a volatile Tuesday, which... 
Via MarketMinute
Topics Economy Supply Chain World Trade
Pfizer CEO Reportedly Says Vaccine Approvals Getting Harder
According to a report from Bloomberg, Bourla said that it's harder to get vaccine approvals and not drug approvals. 
Via Stocktwits
Topics Government World Trade
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks With Over 3% Dividend Yields
 
Via Benzinga
1 Safe-and-Steady Stock Worth Your Attention and 2 We Question
A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
Via StockStory
AI Revolutionizes Quality Control: A New Era of Precision and Speed in Manufacturing, Electronics, and Pharmaceuticals
A groundbreaking wave of Artificial Intelligence (AI) tools is poised to fundamentally transform materials quality checking, ushering in an era of unparalleled precision, speed, and cost-efficiency... 
Via MarketMinute
Topics Artificial Intelligence Economy Fraud
Government Shutdown Casts Long Shadow Over Economy and Interest Rate Outlook Ahead of Powell's Pivotal Speech
The United States government is currently in the throes of its third week of a shutdown, a fiscal impasse that commenced on October 1, 2025, following a congressional failure to enact appropriations... 
Via MarketMinute
Topics Economy Government Regulatory Compliance
These S&P500 stocks are the most active in today's session
Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Tuesday. Discover the stocks that are generating the highest... 
Via Chartmill
Pfizer Seeks Expanded Use Approval For Breast Cancer Drug
Pfizer's Tukysa improved progression-free survival in first-line HER2+ metastatic breast cancer, showing strong efficacy and a manageable safety profile. 
Via Benzinga
Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential
Shah Capital urges Novavax to consider a sale after poor COVID-19 vaccine rollout, highlighting the potential value of at least $5 billion. 
Via Benzinga
David Gardner: 9 Foolish Truths I Hold to Be Self-Evident
Whether you're well steeped in Foolishness or at the beginning stages of your investing journey, these are nine foundational truths not to be forgotten. 
Via The Motley Fool
1 Profitable Stock for Long-Term Investors and 2 Facing Headwinds
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential. 
Via StockStory
Why BrightSpring Health Services (BTSG) Stock Is Trading Up Today
Shares of healthcare services provider BrightSpring Health Services (NASDAQ:BTSG) jumped 3.3% in the afternoon session after several analysts signaled increased confidence in the company, with UBS... 
Via StockStory
Topics Government Initial Public Offering
What's going on in today's session: S&P500 most active stocks
Explore the S&P500 index on Monday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest. 
Via Chartmill
Down 44%, Should You Buy the Dip on Viking Therapeutics?
The company is readying to take on pharma giants Novo Nordisk and Eli Lilly. 
Via The Motley Fool
Where Will Pfizer Be in 5 Years?
Pfizer is working hard to deal with some big headwinds it has coming up, but in five years, this should all be in the past. 
Via The Motley Fool
Topics Intellectual Property World Trade
Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest?
Now may be the time to invest in drug companies, as they just slipped the tariff noose. 
Via The Motley Fool
Topics ETFs Government World Trade
4 Dividend Stocks to Double Up on Right Now -- Including United Parcel Service and Pfizer
These great dividend stocks merit more attention from income investors. 
Via The Motley Fool
Topics Economy Energy Government
MarketBeat Week in Review – 10/06 - 10/10
Investors are eagerly awaiting the start of earnings season for market direction, as the continued government shutdown is creating a lack of economic data 
Via MarketBeat
Topics Economy
Government Shutdown Jitters: 2026 Social Security COLA Back on Track, Averting Further Economic Uncertainty
Washington D.C., October 10, 2025 – The highly anticipated 2026 Social Security Cost-of-Living Adjustment (COLA) announcement, a critical financial marker for nearly 74 million Americans, faced... 
Via MarketMinute
Topics Economy Retirement
US Government Shutdown Rattles Global Markets, Igniting Uncertainty and Fueling Losses on October 10, 2025
The ongoing U.S. federal government shutdown, now in its tenth day as of October 10, 2025, has sent significant tremors through global financial markets. The persistent congressional deadlock over... 
Via MarketMinute
Topics Bonds Economy World Trade
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.